0.1838
Atyr Pharma Inc Azioni (ATYR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
4.85%
10.88
|
11.44 | 14.80 | 26.93 | 20.31 |
| Operating Income/Loss |
4.85%
-10.88
|
-11.44 | -14.80 | -26.75 | -20.31 |
| Nonoperating Income/Loss |
11.34%
0.571
|
0.644 | 0.832 | 0.999 | 0.781 |
| Net Income/Loss |
4.47%
-10.31
|
-10.79 | -13.96 | -25.75 | -19.53 |
| Attributable To Noncontrolling Interest |
0.00%
-0.001
|
-0.001 | -0.001 | -0.002 | -0.001 |
| Basic Average Shares |
0.03%
98.07
|
98.04 | 1.6933 | 97.15 | 90.12 |
| Diluted Average Shares |
0.03%
98.07
|
98.04 | 1.6933 | 97.15 | 90.12 |
| Basic Earnings Per Share |
0.00%
-0.11
|
-0.11 | -0.14 | -0.26 | -0.22 |
| Diluted Earnings Per Share |
0.00%
-0.11
|
-0.11 | -0.14 | -0.26 | -0.22 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):